Samsung Electronics Co., Ltd.

Samsung Display Co., Ltd.

Coway Co., Ltd

The Catholic University of Korea Industry-Academic Cooperation Foundation

Semes Co., Ltd.

Bmi Korea Co., Ltd

Catholic University Industry Academic Cooperation Foundation

Dong-a St Co., Ltd.

Dong-a Pharm. Co., Ltd.

Dong-a Socio Holdings Co., Ltd.

The Catholic University of Korea Industry-Academic Cooperation Foundation, Catholic Univ. of Korea Songeui Campus

The Catholic University of Korea Industry-Academic Corporation Foundation

The Catholic University of Korea Industry-Academic

Sung-Hee Lee

Mi-La Cho

Seon-Yeong Lee

Hyun-Seok Kim

Jae-Hyuk Chang

Min-Jung Park

Dong-Yun Shin

Hye-Jin Son

Jae-Kyung Kim

Seung-Hwan Kim

Min-Uk Kim

Dong-Soo Woo

Eun-Kyung Kim

Dae-Sin Kim

Chul-Woo Yang

Na-Ra Kim

Eun Kyung Kim

Jae-Hoon Kim

Ji-Young Kim

Jung-ho Kim

Woo-Jong Lee

Hyun Joo Lee

Young-il Kim

Seung-jun Lee

Moon-chul Lee

Gug-Rae Jo

Young-Gon Choi

Kee Hyun Nam

Jun-Sang Lyu

Seung-joon Yang

Seong-taek Lim

Hee-moon Jeong

Kyung Hyun Ko

Yong-Sung Roh

Jae Beom Choi

Jung-ho Kang

Tae-sik Park

Yung Bin Chung

Ho Jung Lee

Kyung-lim Kang

Eui Ri Cho

Oh-jae Kwon

Jun Il Kwon

Sung-Hwan Park

Nam-Ok Jung

Eun-Jung Lee

Chang-seok Oh

Koo Woo

Eun-Ji Yang

Yeong-Jun Baik

Jong-Hyun Park

Chang-seung Lee

Bo-Kun Choi

Yong-sung Kim

Myung-Kwan Ryu

Doo-Suk Kang

Chang-youl Moon

Hong-shik Shim

Joo-ho Lee

In-Seok Yeo

Shubhranshu Singh

Ki-beom Lee

In-Seo Kee

Jun-Young Park

Kyoung-seok Son

Jong-ha Lee

Dae-Hwan Jang

Seung-mo Lim

Byeong-Soo Kim

Chan-Jung Park

Young-Gu Lee

Eok-su Kim

Hwa-sun Lee

Choun-Ki Joo

Sua Kim

Sin Kwon

Sung-Worl Jin

Sung-Hyuk Park

Tae-Hun Lim

Seock-Cheon Song

Seoung-Bum Pyoun

Jun-Sub Choi

Jong-Young Choi

Moo-Hi Yoo

Ashish Gupta

Ohjae Kwon

Hee-Ju Kang

Han Feng Chen

Keun-Hwan Kim

Sun-Key Lee

Dong-Hyeon Kim

Seok-Jung Kim

Dae-Sun Kim

Dong-Yub Lee

Hyounmie Doh

Seung-Hun Lee

Byung Ha Chung

Min-Whoa Hong

Kyoung-Woon Kim

Min Jung Park

Display device

An electronic device may include a network interface, a wireless communication circuit configured to support directional communication, a processor electrically connected with the network interface and the wireless communication circuit, and a memory electrically connected with the processor. The memory may store instructions executed to enable the processor to form a first wireless communication channel with a first external electronic device using the wireless communication circuit, form a second wireless communication channel with a second external electronic device using the wireless communication circuit, determine information associated with positions of the first external electronic device and the second external electronic device, detect communication, via the electronic device, between the first external electronic device and the second external electronic device, and enable the first external electronic device and the second external electronic device to directly connect to each other in the frequency band at least partially based on the information.

Electronic device for controlling data communication of external electronic device and communication system

The present invention relates to a mesenchymal stem cell having immunomodulatory activity and a preparation method therefor and, more specifically, to: a rapamycin-treated mesenchymal stem cell having immunomodulatory activity, which expresses any one or more cell surface factors selected from the group consisting of CCR1, CCR2, CCR3, CCR4, CCR7, CCR9 and CXCR4; a cell therapy composition comprising the mesenchymal stem cell, for preventing or treating immune disorders; and a preparation method for the mesenchymal stem cell having immunomodulatory activity. The rapamycin-treated mesenchymal stem cell having immunomodulatory activity, according to the present invention, has increased expression of IDO, TGF-&#x3b2; and IL-10 which are factors having immunomodulatory activity, has decreased expression of Phospho-mTOR, Rictor and Ractor which are signal transduction factors of mTOR, and has increased expression, in the cell, of autophagic inducer Beclin1, ATG5, ATG7, LC3I or LCII. If this cell is used as a cell therapy in individuals having immune disorders, it is possible to effectively treat immune disorders.

MTOR/STAT3 signal inhibitor-treated mesenchymal stem cell having immunomodulatory activity, and cell therapy composition comprising same, for preventing or treating immune disorders

The present invention relates to a biguanide derivative compound capable of effectively preventing and treating immune diseases. The biguanide-based derivative compound according to the present invention inhibits the generation of IL-17 and TNF-&#x3b1;, which are inflammatory cytokines, increases the activity of regulatory T cells having an immunomodulatory function, and exhibits excellent therapeutic effects in animal models of immune diseases. Accordingly, the biguanide-based derivative compound can be usefully used as an immunosuppressant or a pharmaceutical composition capable of preventing or treating various immune diseases, such as autoimmune diseases, inflammatory diseases, and transplant rejection, caused by the dysregulation of immune responses.

Pharmaceutical composition for preventing or treating immune diseases or inflammatory diseases, containing biguanide derivative compound as active ingredient

A nozzle assembly, according to one embodiment of the present invention, comprises; a nozzle case; a nozzle provided in the nozzle case to move forward and backward, and having an ejection hole at one end thereof; and a moving guide member provided at the lower side of the nozzle case so as to reciprocate in the direction intersecting the longitudinal direction of the nozzle case, wherein the nozzle case is coupled to the moving guide member so as to rotate according to a reciprocating motion of the moving guide member.

Nozzle assembly and bidet device including same

A bidet apparatus according to an embodiment of the present invention may comprise: a nozzle case provided inside of a frame; a nozzle, provided in the nozzle case so as to be movable forward and backward, having a discharge outlet at one end thereof; and a drier, provided inside of the frame, for spraying air toward the discharge outlet. As such, a user can dry a nozzle discharge cutlet by only a simple button operation.

Bidet apparatus

Provided is a novel compound capable of effectively preventing and treating immune diseases and a use thereof. The novel compound of the present subject matter has effects of inhibiting the production of inflammatory cytokines, increasing the activity of regulatory T cells having immunoregulatory functions, inhibiting the production of auto-antibodies to regulate excessive immune responses, and inhibiting the differentiation of osteoclasts, and thus can be used for treating immune diseases, such as autoimmune disease, inflammatory disease, and transplant rejection diseases, which are caused by abnormal regulation of various kinds of immune response.

Compound having immune disease treatment effect and use thereof

Various embodiments of the present disclosure relate to a device and method for reducing current consumption in an electronic device. The electronic device may include a communication interface that transmits and receives a signal; and a processor that configures a multi-hop network with at least one other electronic device, and changes the transmission period of a message for a path management of the multi-hop network based on whether the multi-hop network configuration has been changed. Other embodiments are also possible.

Method for reducing current consumption and electronic device therefor

A novel anti-vascular endothelial growth factor (VEGF) antibody having a strong binding affinity for VEGF and capable of inhibiting in vivo tumor growth and a composition for the treatment of cancer, containing the same. The antibody shows a remarkable binding property to human and mouse VEGF, suppresses the proliferation and permeability of a human umbilical vein endothelial cell (HUVEC) and inhibits tumor growth, and thus can be useful as an antibody for the treatment of cancer.

Anti-VEGF antibody, and pharmaceutical composition for preventing, diagnosing or treating cancer or angiogenesis-related diseases, containing same

A semiconductor device includes a field regions in a substrate to define active regions, gate trenches including active trenches disposed across the active region and field trenches in the field regions, and word lines that fill the gate trenches and extend in a first direction. The word lines include active gate electrodes occupying the active trenches, and field gate electrodes occupying the field trenches. The bottom surface of each field gate electrode, which is disposed between active regions that are adjacent to each other and have one word line therebetween, is disposed at a higher level than the bottom surfaces of the active gate electrodes.

Semiconductor device having buried channel array

This invention relates to a stable hyaluronidase liquid formulation comprising a hyaluronidase and a stabilizer for hyaluronidase. In particular, the hyaluronidase has a purity of 95% or more and the specific activity of 70,000 IU/mg or more, and the stabilizer for hyaluronidase contains a buffering agent in order to provide pH of 4.0 to 6.0; 0.001 to 0.5 v/v % of a non-ionic surfactant; and 0.1 to 5 mM of a chelating agent or MgCl. The liquid formulation has advantages in that it stably maintains its activity for a long period of time and may be easily administered than the conventional formulations.

Stabilizer for hyaluronidase and liquid formulation comprising hyaluronidase

A thin film transistor (TFT) and a method of driving the same are disclosed. The TFT includes: an active layer; a bottom gate electrode disposed below the active layer to drive a first region of the active layer; and a top gate electrode disposed on the active layer to drive a second region of the active layer. The TFT controls the conductivity of the active layer by using the bottom gate electrode and the top gate electrode.

Thin film transistor and method of driving same

There are provided a toilet cleaning apparatus having a bubble supply mechanism and a cleaning method thereof. The toilet cleaning apparatus having a bubble supply mechanism includes a mixture tank in which raw water supplied from a raw water supply unit, air introduced from an air supply unit, and a cleaning solution supplied from a cleaning solution supply unit are mixed and accommodated, a bubble generation unit provided in the mixture tank and generating bubbles with the raw water, air, and the cleaning solution by using an impeller, and a bubble discharging unit connected to the mixture tank and discharging bubbles generated by the bubble generation unit to the toilet bowl to cover water stored in the toilet.

Toilet cleaning apparatus having bubble supply mechanism and cleaning method of toilet cleaning apparatus

Growing community of inventors

Suwon-si, South Korea

Sung-Hee Lee